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Abstract
Ovarian primordial follicles are critical for female reproduction and comprise a finite pool of gametes arrested in
development. A systems biology approach was used to identify regulatory gene networks essential for primordial follicle
development. Transcriptional responses to eight different growth factors known to influence primordial follicles were used
to construct a bionetwork of regulatory genes involved in rat primordial follicle development. Over 1,500 genes were found
to be regulated by the various growth factors and a network analysis identified critical gene modules involved in a number
of signaling pathways and cellular processes. A set of 55 genes was identified as potential critical regulators of these gene
modules, and a sub-network associated with development was determined. Within the network two previously identified
regulatory genes were confirmed (i.e., Pdgfa and Fgfr2) and a new factor was identified, connective tissue growth factor
(CTGF). CTGF was tested in ovarian organ cultures and found to stimulate primordial follicle development. Therefore, the
relevant gene network associated with primordial follicle development was validated and the critical genes and pathways
involved in this process were identified. This is one of the first applications of network analysis to a normal developmental
process. These observations provide insights into potential therapeutic targets for preventing ovarian disease and
promoting female reproduction.
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Introduction
An emerging concern in the field of biomedical research is that
the common reductionist approach to studying biological
processes may not be adequate to fully understand the complex
interplay of cellular signaling, gene expression, and other complex
molecular processes that occur within a tissue or organ. Examples
of reductionist studies that have driven much of our understanding
of biological processes associated with complex phenotypes like
disease include the knockout mouse experiments and in vitro
cytokine treatment to assess the effects of gene-specific perturba-
tions on cell or tissue biology. Results from these types of studies
provide information on candidate regulatory factors, but typically
do not elucidate the network of factors or processes required for a
normal developmental biology or pathobiology. A holistic, systems
biology, approach to studying normal developmental processes
can be a powerful tool that is complementary to the more
reductionist experiments. In the spirit of a systems-based approach
to development, the current study was designed to identify gene
networks involved in ovarian primordial follicle development and
to characterize critical regulatory factors involved in this
development process.
In mammals, all the oocytes (eggs) that will be used over a
female’s lifetime are present in the ovary at birth in a finite pool.
These oocytes are arrested in prophase of the first meiotic division
and are each surrounded by flattened pre-granulosa cells to form a
structure called a primordial follicle [1]. During the reproductive
lifespan of a female, follicles gradually leave the arrested pool to
undergo a primordial to primary follicle transition. A follicle
undergoing follicle transition has an increase in oocyte diameter
and the associated granulosa cells proliferate and change from a
flattened to cuboidal in shape. Once primordial to primary follicle
transition has occurred the follicle either continues to develop to
the point of ovulation or undergoes atresia [1,2,3,4]. Previously
cell-to-cell communication with extra-cellular growth factors has
been shown to regulate the initiation of primordial follicle
development. These studies have primarily used a reductionist
approach to test candidate growth factors one at a time for their
ability to affect follicle transition. A number of paracrine growth
factors have been identified as having a role in early follicle
development (reviews [4,5]).
To move beyond examining single gene effects on this
development process, gene network analysis can be employed to
identify groups (e.g. modules) of genes whose expression is
regulated in a coordinated manner (gene network) [6,7,8]. In this
type of analysis, a biological system is surveyed in the context of
disease (or other interesting phenotypes) with microarrays multiple
times with and without perturbations that cause the system to
change. A novel bioinformatics analysis is used to identify modules
of genes associated with biological systems (bionetwork). The great
majority of network analyses have focused on disease states and
been used to better understand the systems biology of disease
processes and identify potential therapeutic targets [9,10,11,
12,13,14,15]. The current study was designed to determine if
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process.
The current study used whole rat ovaries cultured in vitro in a
manner that allowed primordial to primary follicle transition. The
ovaries were treated with one of eight different growth factors
previously shown to regulate primordial follicle transition in
comparison to untreated control cultures. The mRNA was isolated
from the ovaries and used for microarray transcriptome analysis to
globally survey gene expression under these different treatment
conditions. The effects of each growth factor on gene expression
were analyzed to determine similarities and differences in gene
expression between the different growth factor treatments. Those
genes whose mRNA expression changed with any treatment were
subjected to network analysis to identify pathways and genes with
a high degree of connectivity between other genes and pathways.
From the networks constructed from these data we identified a list
of critical modules of regulated genes forming gene sub-networks
that were used to identify regulatory genes involved in primordial
follicle development. Not only were previously identified regula-
tory factors/genes associated with this process identified from this
network analysis, but a number of putative regulators of follicle
transition not previously associated with this process were also
determined. One of the new candidate genes, connective tissue
growth factor (Ctgf) [16], was tested experimentally and found to
promote primordial to primary follicle transition. Observations
demonstrate the utility of this network analysis to be used as a
systems biology approach to study normal developmental
processes in complex systems.
Results
Primordial Follicle Transcriptome Analysis
A number of regulatory factors have been shown to affect
primordial to primary follicle transition, including Amh [17,18],
Fgf2 [19,20,21], Bmp4 [22,23], Gdnf [24], Fgf7/KGF [25], Kitlg
[19,26,27], Lif [28] and Pdgfa [29]. In order to determine the
underlying gene networks and processes involved in primordial
follicle development, microarray analysis was performed on RNA
from whole rat ovaries treated for two days in vitro with each of
the above listed growth factors independently. There were three
independent RNA samples of pooled ovaries for each growth
factor treatment (except for GDNF, which had only two sample
replicates), and corresponding control samples for a total of 38
RNA samples. These were evaluated using 38 Affymetrix Rat
Gene 1.0 ST microarrays. The array data were analyzed together
using normalization and pre-processing described in the Methods.
Each growth factor treatment resulted in 79 to 349 genes with
altered expression compared to controls (Figure 1). The lists of the
genes affected by each treatment are presented in Table S1. There
were relatively few genes with altered expression in common
between the different treatments (Figure 1). Less than 10% of the
genes changed by any one growth factor treatment were found to
be changed in any other treatment. The exception was Fgf7/KGF,
which had a more than 30% overlap of altered genes with Amh.
There were no individual genes that changed expression levels
in response to more than three of the eight original treatments
(Table S1).
The complete list of genes whose expression levels changed with
any of the treatments was compared to curated lists of genes from
the KEGG database to identify processes that may be important
for primordial follicle development. Automated unbiased match-
ing of lists of affected genes to KEGG pathways was performed
with Pathway Express (Intelligent Systems and Bioinformatics
Laboratory; http://vortex.cs.wayne.edu/ontoexpress/). Pathways
heavily impacted by genes whose expression altered in response to
the growth factor treatments (Table 1) included pathways involved
in cell surface and extracellular matrix regulation (cell adhesion
molecules, adherens junction, focal adhesion, tight junction, gap
junction, regulation of actin cytoskeleton), known signaling
pathways (MAPK, notch, B-cell receptor, adipocytokine, toll-like
receptor, ErbB, GnRH, Wnt, hedgehog, VEGF, Jak-STAT, TGF-
beta, p53, insulin, PPAR), the complement cascade, axon
guidance, glycan structure biosynthesis and pathways listing cell
communication ligand-receptor interactions (cytokine-cytokine
receptor, neuroactive ligand-receptor, ECM-receptor). There
was a high degree of overlap of affected pathways between
different growth factor treatments (Figure 1). For the list of
pathways containing altered genes, from 70% to 82% of those
pathways are shared with at least one other treatment. Application
of the hypergeometrical Fisher Exact Test to assess whether the
number of overlapped pathways was significantly greater than
expected by chance, revealed that the majority were statistically
significant. The pathways containing altered genes from several
growth factor treatments are presented in Table 1. Although few
altered genes were found to overlap between different treatments
(Figure 1), each growth factor treatment influenced similar
pathways, Table 1 and Table S1. Therefore, each growth factor
affects similar pathways via different genes.
Bionetwork Analysis
The complete list of genes whose expression levels changed with
any growth factor treatment was subjected to a network analysis as
described in Methods. Potential batch effects for culture date,
RNA processing data and microarray performance date were
corrected during the analysis, with no major effect on the analysis.
The data were fit using a robust linear regression model (rim
function from R statistical package), and then the residuals with
respect to the model fit were carried forward in all subsequent
analysis. The network analysis scores each gene according to how
Figure 1. Number of genes and pathways overlapped between
signature (growth factor treatment group) lists. Total number of
differentially expressed genes for each growth factor is shown in dark
yellow column, number of genes overlapped between each pair of
signature lists – in light yellow columns. Total number of KEGG
pathways affected by each growth factor is shown in dark green row;
number of KEGG pathways overlapped for each pair of growth factors is
shown in light green row. CTGF analysis separate from the network
analysis.
doi:10.1371/journal.pone.0011637.g001
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correlated with the changes in expression of every other gene. This
gives a connectivity score for each gene. High connectivity scores
indicate that expression of this gene changes in concert with that of
many other genes. In addition, the network analysis identifies gene
modules in which the member genes have similar changes in
expression in response to the various growth factor treatments.
Gene modules are functional components of the network that are
often associated with specific biological processes. To identify
modules comprised of highly interconnected expression traits
within the co-expression network, we examined the topological
overlap matrix [30] associated with this network. The topological
overlap between two genes not only reflects their more proximal
interactions (e.g., two genes physically interacting or having
correlated expression values), but also reflects the higher order
interactions that these two genes may have with other genes in the
network. Figure 2 depicts a hierarchically clustered topological
overlap map in which the most highly interconnected modules in
the network are readily identified. The specific details of the gene
co-expression network analysis (Figure 2) are presented in the
Methods section. To identify gene modules (sub-networks)
formally from the topological overlap map, we employed a
previously described dynamic cut-tree algorithm with near optimal
performance on complicated dendrograms [31] (see Methods for
details). Figure 2 shows the topological overlap map of the co-
expression network with gene modules color-coded for the 16
modules identified. The membership of each module can be found
in Table S1. The sixteen modules contained 1,383 genes with the
remaining 157 genes (colored as gray) not failing into any module.
The pathways containing genes whose expression changed with
growth factor treatment were compared to the genes from each
module that were associated with specific pathways (Table 1 and
Table S1 for full list). For most pathways genes from several
network modules were present. However, several pathways were
associated with selected modules. For example, out of 19 altered
genes present in the focal adhesion pathway, seven were from the
turquoise module and seven from the brown. Similarly, of the five
altered genes in the Wnt signaling pathway three were from the
turquoise module. For the fifteen changed genes in the cell
adhesion molecule pathways three were from blue and three from
magenta modules. Those genes whose expression changed with
specific growth factor treatments were cross-matched with the
genes assigned to each network module to determine if specific
modules were heavily influenced by particular growth factors.
Interestingly, each module was biased toward having many genes
in common with selected growth factors (Table S1). In contrast,
some growth factor treatments induced changes in genes that were
distributed among several different modules.
In order to identify genes that could be key regulators of
primordial follicle development, a shorter list of candidate genes
was generated from the results of the network analysis. Six
modules were chosen for having the highest numbers of known
Figure 2. The ovary gene co-expression network and corresponding gene modules. A topological overlap matrix of the gene co-
expression network consisting of the 1540 genes regulated by the various growth factors. Genes in the rows and columns are sorted by an
agglomerative hierarchical clustering algorithm (see Methods). The different shades of color signify the strength of the connections between the
nodes (from white signifying not significantly correlated to red signifying highly significantly correlated). The hierarchical clustering (top) and the
topological overlap matrix strongly indicate highly interconnected subsets of genes (modules). Modules identified are colored along both column
and row and are boxed. The number of genes in each module is listed as size of module.
doi:10.1371/journal.pone.0011637.g002
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red, purple). The top 10% of most connected transcripts in each of
the six modules were identified as potential important regulators
[13,15], except for the blue module for which the top 20% were
chosen since so many of that module’s most highly connected
transcripts were not annotated as genes. The compiled list
included 55 transcripts annotated as genes (Table 2), and these
genes were subjected to more intensive investigation.
An automated unbiased analysis of published scientific literature
was applied to the lists of differentially expressed genes described
above using Genomatix/BiblioSphere software, as described in the
Methods. Figure 3 shows a small integrated gene network among
the short list of the 55 candidate regulators (Table 2). These
relationships in literature raise the possibility that physiological
interactions exist between these genes. The gene Ctgf (Connective
tissue growth factor) was seen to relate to several other genes with
high connectivity, Figure 3. Interestingly, two of the identified
genes were previously shown to influence primordial follicle
development, Pdgfa [29] and Fgfr2 [19,20,21].
The entire set of 1540 transcripts differentially expressed with
growth factor treatment was also subjected to analysis using
BiblioSphere. Only 632 were recognized by BiblioSphere and 613
were connected. A diagram of literature relationships between
these genes is presented in Figure S1. Five major gene clusters
were identified as associated with Nfkb1, Vegfa, Gadd45a, Esr1
and Egfr1. This analysis is useful to compare with the expression
network analysis, but is biased toward the literature and finding
relationships among more heavily studied factors.
Analysis of CTGF Actions
Critical regulatory candidates for primordial follicle develop-
ment were selected due to their being differentially expressed in
response to treatment with growth factors, having a high
connectivity score, and being related in literature to other highly
connected genes. For the purpose of the current study, candidate
regulatory genes that were also extracellular growth factors were
considered. Therefore, CTGF was selected based on all these
criteria for further analysis. Experiments were performed to see if
CTGF could regulate primordial to primary follicle transition.
Ovaries from four-day old rats were treated with 50ng/ml CTGF
protein for ten days in an organ culture system as described in the
Methods (Figure 4A and 4B). Transforming growth factor beta 1
(TGFB1), which is known to interact with CTGF [32,33], was also
tested. Untreated cultured ovaries were used as a negative control,
and ovaries treated with 50ng/ml each of Kit ligand (KITL) and
Fibroblast growth factor 2 (FGF2) were used as a positive control.
CTGF treatment resulted in a significant (p,0.05) increase in
developing follicles compared to untreated controls, as did
treatment with the combination of KITL and FGF2 (Figure 4C).
TGFB1 had no effect, either alone or in combination with CTGF.
RNA was collected from CTGF and control cultured ovaries as
described in the Methods from three replicate experiments. The
RNA was used for microarray analysis using the same criteria as
for the other growth factors used in the network analysis. One
hundred fifty-five transcripts were differentially expressed in
CTGF-treated ovaries, Table S1. As was seen for the other
growth factors used in the network analysis, there was little overlap
of these changed genes with the genes showing changed expression
in response to any other growth factor treatment, Figure 1.
However, as seen among the other growth factors, there was a
high degree of overlap between the pathways impacted by CTGF
treatment and treatment with other growth factors (Figure 1).
Therefore, a critical regulatory gene predicted from the network
analysis was confirmed to regulate primordial follicle development.
Discussion
A systems biology approach was used to elucidate the changes in
gene expression that are important for ovarian primordial to
primary follicle transition. A gene network analysis was performed
on the ovarian transcriptomes following treatment with 8 different
growth factors. The rat ovary was used as a model system to test
the utility of this approach in investigating a normal developmen-
tal process. This is one of the first applications of network analysis
to a normal developmental process. The objective was to identify
critical regulatory factors and pathways in primordial follicle
development following a bionetwork analysis.
Microarray analysis determined the alterations in the ovarian
transcriptome that occurred in response to treatment of ovaries with
A M H,F GF 2 ,B M P 4 ,G D N F ,F G F 7 ,K I T L ,L I F ,a n dP D GF B .A l lo f
these have previously been shown to effect follicle transition
[17,18,19,20,21,22,23,24,25,26,27,28,29,34]. All these factors stimu-
late primordial follicle development except AMH that inhibits follicle
development. The presence of both positive and negative factors
provides a wider diversity of gene regulation to facilitate the network
analysis. As expected the AMH regulated gene set is more distinct
from the others. Surprisingly, there were few altered genes in
common between all these growth factors and there were no genes
that significantlychanged in expression level in responseto morethan
three of the eight growth factors. In contrast, the physiological
processes impacted by these altered genes were found to have a
higher level of overlap. Since a pathway includes groups of genes, it is
expected that the overlap of pathways between growth factor
treatments will be higher. The overlap of pathways was markedly
high (70% to 82%) and statistically different, suggesting pathway
associations provide a predicted capacity to identify regulatory
factors. Certain pathways were significantly over-represented in the
pool of genes with changed expression. This suggests that there are
selected physiological pathways that are influenced by all the different
growth factors (Figure 5), but that each growth factor affects different
genes at different points in these pathways (Table 1). Multiple input
points into these physiological pathways could allow for more precise
regulation and more effective compensation between the growth
factors. Since many growth factors are acting in parallel to regulate
these pathways, any one pathway system is robust and maintains
function if one growth factor becomes inoperative. Since primordial
follicle development is essential for female reproduction, a complex
network of regulatory factors influencing different aspects of critical
signaling pathways has evolved.
For the eight growth factors evaluated the cellular processes
affected in common (Figure 5) included changes in cell contact,
morphogenesis, and cell proliferation and differentiation. These
are processes that are necessary for the morphological changes
that occur with primordial to primary follicle transition. During
follicle transition granulosa cells change from squamous to
cuboidal and the oocyte starts to grow in diameter (Figure 4B).
Unexpectedly, what was also seen as an important affected cellular
process was regulation of several key components of the
complement and coagulation cascades (Figure S2). These genes
are not known for having roles in ovary or follicle development,
and merit further investigation.
Gene networks provide a convenient frameworkfor exploring the
context within which single genes operate. For gene networks
associated with biological systems,thenodesinthe network typically
represent genes, and edges (links) between any two nodes indicate a
relationship between the two corresponding genes. An important
end product from the gene co-expression network analysis is a set of
gene modules which member genes are more highly correlated with
each other than with genes outside a module. It has been
Primordial Follicle Bionetwork
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11637Table 2. List of 55 Candidate Regulatory Genes.
Function GeneSymbol GeneBank Probeset k.in* Module
Regulation by
Growth Factor GeneTitle
Apoptosis Bcl2l10 NM_053733 10911690 10.0 red KL-dwn BCL2-like 10
Cell Cycle Cdkn2c NM_131902 10878705 7.6 red KL-dwn CDK4 inhibitor 2C
ECM Cdh3 NC_005118 10807525 28.0 turq AMH-dwn cadherin 3, type 1, P-cadherin
Col11a1 AJ005396 10818502 20.6 brown KL-dwn collagen, type XI, alpha 1
Krt19 NM_199498 10747262 25.2 turq AMH-dwn keratin 19
Lama5 NC_005102 10852270 30.9 turq AMH-dwn laminin, alpha 5
Development Bnc2 NM_001106666 10877880 26.5 turq AMH-dwn basonuclin 2
Emx2 NM_001109169 10716454 27.5 turq KGF-dwn empty spiracles homeobox 2
Usmg5 NM_133544 10730633 13.5 blue AMH, GDNF-dwn muscle growth 5 homolog (mouse)
Epigenetics Dnmt1 NM_053354 10915437 22.9 brown KL-dwn DNA (cytosine-5-)-methyltransferase 1
Golgi B4galt6 NM_031740 10803394 11.7 blue AMH-dwn, KGF-dwn galactosyltransferase, polypeptide 6
Growth Factors Ctgf NM_022266 10717233 8.2 blue KGF-up, LIF-dwn connective tissue growth factor
Il16 NM_001105749 10723351 31.9 turq AMH-dwn, KGF-dwn interleukin 16
Pdgfa NM_012801 10757129 27.0 turq AMH-dwn, KGF-dwn platelet-derived growth factor
Immune LOC287167 NM_001013853 10741765 21.6 brown KL-dwn globin, alpha
Metabolism Cacna2d3 NM_175595 10789819 19.9 brown KL-dwn calcium channel
Hbq1 XM_001061675 10741761 24.0 brown KL-dwn hemoglobin, theta 1
Hhatl NM_001106868 10914424 15.7 yellow PDGF-up hedgehog acyltransferase-like
Hmgcs2 NM_173094 10817759 19.5 brown KL-dwn Coenzyme A synthase 2
Hsd11b1 NM_017080 10770795 17.0 yellow BMP4-dwn hydroxysteroid 11-beta dehydro
Kirrel NM_207606 10824123 14.1 yellow AMH-dwn kin of IRRE like (Drosophila)
Plod2 NM_175869 10912255 18.3 brown KL-dwn procollagen lysine, 2-oxoglutarate
Podxl NM_138848 10861662 26.6 turq AMH-dwn, KGF-dwn podocalyxin-like
Scn3a NM_013119 10845809 17.4 brown KL-dwn sodium channel, type III, alpha
Slc4a4 NM_053424 10775997 29.0 turq AMH-dwn, KGF-dwn solute carrier family 4
Slc7a5 NM_017353 10811531 15.6 yellow PDGF-up solute carrier family 7
Slc29a1 NM_031684 10921833 15.4 yellow PDGF-up solute carrier family 29
Eno1 NM_012554 10874152 9.0 purple PDGF-up enolase 1, (alpha)
Receptors Axl NM_031794 10719900 15.4 yellow BMP4-dwn Axl receptor tyrosine kinase
Ednrb NM_017333 10785724 20.7 brown KL-dwn endothelin receptor type B
Fgfr2 NM_012712 10726172 30.8 turq AMH-dwn, KGF-dwn fibroblueast growth factor receptor 2
Itgb3bp NM_001013213 10878272 11.0 blue GDNF-dwn integrin beta 3 binding protein
Plxna4a NM_001107852 10861678 30.9 turq AMH-dwn, KGF-dwn plexin A4, A
Tmem151a NM_001107570 10727725 26.2 turq AMH-dwn, KGF-dwn transmembrane protein 151A
Signaling Nrgn NM_024140 10916228 16.1 yellow AMH, KGF-dwn, PDGF-up neurogranin
Dusp4 NM_022199 10792035 17.3 yellow AMH-dwn dual specificity phosphatase 4
Dusp6 NM_053883 10895144 16.6 yellow BMP4-dwn dual specificity phosphatase 6
Efna5 NM_053903 10930204 15.0 yellow AMH, GDNF-dwn ephrin A5
Map3k1 NM_053887 10821276 26.8 turq KGF-dwn mitogen activated protein kinase
Pde7b NM_080894 10717069 17.8 brown KL-dwn phosphodiesterase 7B
Rem1 NM_001025753 10840861 14.5 yellow PDGF-up RAS (RAD and GEM)-like
Shc4 NC_005102 10849423 17.0 yellow AMH-dwn SHC family, member 4
Ubash3b AC_000076 10916476 16.9 yellow PDGF-up ubiquitin associated
Transcription Btg4 NM_001013176 10909937 7.4 red KL-dwn B-cell translocation gene 4
Etv5 NM_001107082 10752034 14.4 yellow AMH-dwn ets variant 5
Fbxo15 NM_001108436 10803025 11.9 red KL-dwn F-box protein 15
Misc. & Unknown Depdc2 NM_001107899 10875023 29.5 brown KL-dwn DEP domain containing 2
Fam154a AC_000073 10877890 11.4 red KL-dwn similarity 154, member A
LOC686725 AC_000076 10915208 25.9 turq AMH-dwn hypothetical protein LOC686725
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biological pathways for genes that associate with disease traits and
for genes that are linked to common genetic loci [6,35].
The current study employed a weighted gene co-expression
network approach that has been extensively used for uncovering
biologically meaningful gene modules [7,13,15] to explore novel
pathways involved in primordial follicle development. An unsuper-
vised and unbiased approach was used to nominate potential
regulatory candidates for these modules based on gene network
connectivity. The connectivity score shows how well under different
treatments the changes in gene expression for a gene are correlated
with the changes in expression for every other gene. In the current
study, the gene co-expression network analysis helped select 55
highly connected genes for further functional analysis. An
automated literature search of these 55 genes revealed a sub-
network relationship among them as presented in Figure 3. This
sub-network suggested regulatory roles for Pdgfa and Fgfr2 (the
receptor) for Fgf2 and Fgf7 (KGF). PDGF, KGF/FGF7 and FGF2
proteins have previously been shown to regulate primordial to
primary follicle transition [29,34]. Therefore, the bionetwork
predicted to be involved in the regulation of primordial follicle
development identified two previously known regulatory factors
which validated the utility of the network analysis for identifying
candidate regulatorygenes,consistentwith previousnetworkstudies
[13,15]. This sub-network also identified connective tissue growth
factor (Ctgf) [16,36] as a putative regulator of primordial follicle
development. An ovarian organ culture experiment confirmed that
CTGF promotes primordial to primary follicle transition. There-
fore, a regulatory factor predicted to be important for primordial
follicle development was confirmed to be involved which further
validated the bionetwork approach. A microarray analysis of
CTGF-treated ovaries showed an altered gene set similar to those of
the other growth factors known to regulate follicle transition. These
observations validate the network-based systems biology approach
to elucidate the regulation of a complex developmental process.
Consideration of the 55 intra-module hub genes from critical
regulatory modules revealed a number of signaling and cellular
processes were influenced, Figure 5 and Figure S3. In the growth
factor/chemokine family Pdgfa and Ctgf were confirmed to be
involved. The IL16 identified is currently being investigated as a
potential regulatory candidate. The specific genes identified in
Table 2 and associated regulatory processes provide potential
therapeutic targets to regulate primordial follicle development.
The ability to inhibit or stimulate primordial follicle development
with a therapeutic treatment has a number of clinical applications.
A delay in primordial follicle development and maintenance of the
primordial pool could delay the onset of menopause and extend
the reproductive life span of a female. In addition, the ability to
therapeutically inhibit primordial follicle development would
provide a treatment for premature ovarian failure, a disease when
the primordial pool is lost early in life causing female infertility. In
contrast, the therapeutic stimulation of primordial follicle
development could treat forms of female infertility [4]. The
induction of primordial follicle development also could promote
the loss of the primordial pool and induce female sterility. The
bionetwork identified in the current study produced a number of
potential therapeutic targets to manipulate primordial follicle
development and female reproductive capacity.
The systems biology approach taken with this network analysis
of primordial follicle development identified clusters and modules
of genes involved in this critical development process. A number of
the growth factors previously shown to be involved (e.g. PDGF
and bFGF) were identified, but other factors known to be
important for ovarian development were not identified. Often a
reductionist approach such as a knockout mouse model can
Function GeneSymbol GeneBank Probeset k.in* Module
Regulation by
Growth Factor GeneTitle
RGD1306186 BC090317 10881318 9.2 red KL-dwn similar to RIKEN cDNA 4930569K13
RGD1306622 XM_001074493 10728647 32.6 turq AMH-dwn, KGF-dwn similar to KIAA0954 protein
RGD1308023 XR_006437 10850490 17.6 brown KL-dwn, LIF-dwn similar to CG5521-PA
RGD1566021 AC_000086 10800122 19.6 brown KL-dwn similar to KIAA1772
Short list of 55 genes that are the most connected genes with known functions in the modules of interest.
Selected from the top 10% most connected genes in each module (except blue module for which considered top 20% as many hubs are not annotated. Abbreviations
used: dwn - down-regulated; up - up-regulated; (*)- k in. is connectivity coefficient obtained/calculated in network analysis.
doi:10.1371/journal.pone.0011637.t002
Table 2. Cont.
Figure 3. Sub-network connection scheme for the most highly
connected 55 candidate genes obtained by global literature
analysis. Only 15 connected genes from the list of 55 are shown, while
the rest are not connected and not shown. Red and yellow colors
represent up-regulated genes, blue and turquoise colors – down-
regulated genes.
doi:10.1371/journal.pone.0011637.g003
Primordial Follicle Bionetwork
PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11637identify a factor as being important for the maintenance of tissue
development or function, but this does not mean the factor is
regulated during the process. In addition, critical developmental
processes such as primordial follicle development often have a set
of compensatory factors that have evolved such that loss of any one
will still allow the process to proceed. Therefore, knockout models
often do not have phenotypes for these factors. This does not mean
the factor is not important, but instead that the developmental
process is essential and thus multiple factors compensate to assure
the developmental process occurs. The current study takes a
systems biology approach to identify networks of genes involved in
the process without the bias of a reductionist model. Therefore,
novel groups of factors and cellular processes were identified that
now require further investigation.
The integrative analysis revealed a gene sub-network involved
in primordial follicle development to elucidate the basic develop-
mental biology of this process and provide potential therapeutic
targets for ovarian disease and function. This sub-network was
validated by the presence of two genes previously identified as
being important. A new gene identified, Ctgf, was tested and
found to regulate primordial follicle development. Therefore, the
network based systems biology approach was partially validated
for a normal developmental process. This type of approach will
likely be invaluable to study development on a systems biology
level in the future.
Materials and Methods
Ovarian organ culture
Four-day old female Sprague-Dawley rats (Harlan Laborato-
ries, Inc., USA) were euthanized according to the laboratories
Washington State University IACUC approved (#02568-014)
Figure 4. Analysis of the role of CTGF in primordial follicle transition. A) Hematoxylin-eosin stained ovary sections showing a representative
arrested primordial follicle (left), and a developing primary follicle after having undergone primordial to primary follicle transition (right). B) Graphic
representation of primordial and primary follicles. C) Effect of CTGF on cultured ovaries. Ovaries were cultured for 10 days with the treatments
indicated. Ovarian histological analysis determined the percentage of primordial versus developing follicles for each ovary. Bars are the mean percent
developing follicles 6 SEM. N=5–7 per treatment from four different replicate experiments. Asterisks indicate a significant (*p,0.05 or ***p,0.01)
difference from control by Dunnet’s post-hoc test after a significant result of ANOVA.
doi:10.1371/journal.pone.0011637.g004
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described previously [24]. Four-day old rat ovaries contain
almost exclusively primordial follicles. For ovary culture
experiments in which ovarian RNA was collected, 2–3 ovaries
per well were cultured with media changes every 24 hours for
two days in the absence (controls) or presence (treated) of either
AMH (human Anti-Mu ¨lerian hormone)(50ng/mL, R&D Sys-
tems Inc., USA), FGF2 (rat Fibroblast growth factor 2)(50ng/
mL, R&D Systems Inc., USA), BMP4 (human Bone morpho-
genetic protein 4)(50ng/mL, R&D Systems Inc., USA), GDNF
(rat Glial derived neurotrophic factor)(50ng/mL, Calbiochem,
USA), FGF7 (human fibroblast growth factor 7/keratinocyte
growth factor)(50ng/mL, R&D Systems Inc., USA), KITLG
(mouse Kit ligand)(50ng/mL, R&D Systems Inc., USA), LIF (rat
leukemia inhibitory factor)(50ng/mL, Chemicon/Millipore,
USA), PDGF-AB (rat platelet derived growth factor AB
heterodimer)(50ng/mL, R&D Systems Inc., USA), TGFb1
(human transforming growth factor beta 1)(50ng/mL, R&D
Systems Inc., USA) or CTGF (human connective tissue growth
factor)(50ng/mL, PeproTech Inc., NJ USA). After only two days
of culture there are no morphological differences between
control and growth factor-treated ovaries, so measurements of
whole-ovary gene expression reflect differences in RNA tran-
scription, rather than differing proportions of cell types due to
differing cell proliferation between treatments.
In order to determine the effect of CTGF on primordial to
primary follicle development, ovaries were cultured as above for
ten days in the absence or presence of CTGF (50ng/mL), alone or
in combination with TGF-beta1 (50ng/mL). After culture ovaries
were fixed with Bouin’s solution, paraffin embedded, sectioned
onto microscope slides and stained with hematoxylin and eosin as
described previously [24].
Morphometric Analysis
The number of follicles at each developmental stage was counted
and averaged in two serial sections from the largest cross-section
through the center of the ovary. Total follicle number has not been
found to change between treatment groups. Rather, only the
percentage of follicles at each developmental stage changes with
treatment [28,34]. KL was used as a positive control for the organ
culture experiments. Follicles in ovarian cross sections were
classified as primordial (stage 0), or developing (stages 1–4: early
primary, primary, transitional and preantral) as previously de-
scribed [37]. Primordial follicles consist of an oocyte arrested in
prophase I of meiosis that is partially or completely encapsulated by
flattened squamous pregranulosa cells. Early transition primary
follicles have initiated development (i.e., undergone primordial to
primary follicle transition) and contain at least two cuboidal
granulosa cells. Primary and preantral follicles exhibit one or more
complete layers of cuboidal granulosa cells. Four-day old ovaries
Figure 5. Scheme of direct connections to cellular processes for the 55 candidate regulatory genes obtained by global literature
analysis. Only 19 connected genes from the list of 55 are shown, the rest are not connected and not shown. Node shapes code: oval and circle –
protein; crescent – protein kinase and kinase; diamond – ligand; irregular polygon – phosphatase; circle/oval on tripod platform – transcription factor;
ice cream cone – receptor. Red color represents up-regulated genes, blue color – down-regulated genes, grey rectangles represent cell processes;
arrows with plus sign show positive regulation/activation, arrows with minus sign – negative regulation/inhibition.
doi:10.1371/journal.pone.0011637.g005
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eosin stained ovarian sections were analyzed at 4006magnification
using light microscopy. Follicles containing degenerating red eosin-
stained oocytes were not counted.
RNA preparation
RNA was isolated from whole rat ovaries after homogenization
in one ml Trizol
TM reagent (Sigma-Aldritch, USA), according to
manufacturer’s instructions. Two or three ovaries from the same
culture well (from different rat pups out of the same litter) and
receiving the same treatment were pooled and homogenized
together. On any given day a culture experiment was performed,
the treatment groups included untreated control ovaries and one
to three different growth factor treatments. Homogenized samples
were stored at 270 C until the time of RNA isolation. After
isolation from Trizol, RNA was further purified using RNeasy
MinElute Cleanup Kits (Qiagen, USA) and stored in aqueous
solution at 270 C.
Microarray Analysis
The microarray analysis was performed by the Genomics Core
Laboratory, Center for Reproductive Biology, Washington State
University, Pullman, WA using standard Affymetrix reagents and
protocol. Briefly, mRNA was transcribed into cDNA with random
primers, cRNA was transcribed, and single-stranded sense DNA
was synthesized which was fragmented and labeled with biotin.
Biotin-labeled ssDNA was then hybridized to the Rat Gene 1.0 ST
microarrays containing 27,342 transcripts (Affymetrix, Santa
Clara, CA, USA). Hybridized chips were scanned on Affymetrix
Scanner 3000. CEL files containing raw data were then pre-
processed and analyzed with Partek Genomic Suite 6.3 software
(Partek Incorporated, St. Louis, MO) using an RMA GC-content
adjusted algorithm. Raw data pre-processing was performed in 2
groups. The first group containing 38 samples CEL files were pre-
processed in Partek all together as one experiment. Comparison of
all array histogram graphs demonstrated the data for all 38 chips
were similar and appropriate for further analysis. The second
group of samples for microarray analysis consisting of 3 CTGF-
treated and 3 corresponding control ovaries was run, pre-
processed and analyzed post factum, separately from the rest of
the samples as a result of a discovery from network analysis. Partek
pre-processing algorithm for these 6 CEL files used the same
criteria as used for the first group.
The microarray quantitative data involves over 10 different
oligonucleotides arrayed for each gene and the hybridization must
be consistent to allow a statistically significant quantitative
measure of gene expression and regulation. In contrast, a
quantitative PCR procedure only uses two oligonucleotides and
primer bias is a major factor in this type of analysis. Therefore, we
did not attempt to use PCR based approaches as we feel the
microarray analysis is more accurate and reproducible without
primer bias such as PCR based approaches.
All microarray CEL files (MIAME compliant raw data) from
this study have been deposited with the NCBI gene expression and
hybridization array data repository (GEO, http://www.ncbi.nlm.
nih.gov/geo) (GEO Accession number: GSE20324), all arrays
combined with one accession number, and can be also accessed
through www.skinner.wsu.edu. For gene annotation, Affymetrix
annotation file RaGene1_0stv1.na30.rn4.transcript.csv was used
unless otherwise specified.
Network analysis
The network analysis was restricted to genes differentially
expressed between the control and the treatment groups based on
previously established criteria: (1) fold change of group means
$1.2 or #0.83; (2) T test p-value #0.05; and (3) absolute
difference of group means $10. The union of the differentially
expressed genes from the different treatments resulted in 1,540
genes being identified and used for constructing a weighted gene
co-expression network [7,8]. Unlike traditional un-weighted gene
co-expression networks in which two genes (nodes) are either
connected or disconnected, the weighted gene co-expression
network analysis assigns a connection weight to each gene pair
using soft-thresholding and thus is robust to parameter selection.
The weighted network analysis begins with a matrix of the Pearson
correlations between all gene pairs, then converts the correlation
matrix into an adjacency matrix using a power function f(x)=x
b.
The parameter b of the power function is determined in such a
way that the resulting adjacency matrix (i.e., the weighted co-
expression network), is approximately scale-free. To measure how
well a network satisfies a scale-free topology, we use the fitting
index proposed by Zhang & Horvath [7] (i.e., the model fitting
index R
2 of the linear model that regresses log(p(k)) on log(k) where
k is connectivity and p(k) is the frequency distribution of
connectivity). The fitting index of a perfect scale-free network is
1. For this dataset, we select the smallest b (=7)which leads to an
approximately scale-free network with the truncated scale-free
fitting index R
2 greater than 0.75. The distribution p(k) of the
resulting network approximates a power law: p(k),k
21.29.
To explore the modular structures of the co-expression network,
the adjacency matrix is further transformed into a topological
overlap matrix [30]. As the topological overlap between two genes
reflects not only their direct interaction, but also their indirect
interactions through all the other genes in the network. Previous
studies [7,30] have shown that topological overlap leads to more
cohesive and biologically meaningful modules. To identify
modules of highly co-regulated genes, we used average linkage
hierarchical clustering to group genes based on the topological
overlap of their connectivity, followed by a dynamic cut-tree
algorithm to dynamically cut clustering dendrogram branches into
gene modules [39]. A total of sixteen modules were identified and
the module size was observed to range from 20 to 194 genes.
To distinguish between modules, each module was assigned a
unique color identifier, with the remaining, poorly connected
genes colored grey. The hierarchical clustering over the topolog-
ical overlap matrix (TOM) and the identified modules is shown. In
this type of map, the rows and the columns represent genes in a
symmetric fashion, and the color intensity represents the
interaction strength between genes. This connectivity map
highlights that genes in the ovary transcriptional network fall into
distinct network modules, where genes within a given module are
more interconnected with each other (blocks along the diagonal of
the matrix) than with genes in other modules. There are a couple
of network connectivity measures, but one particularly important
one is the within module connectivity (k.in). The k.in of a gene was
determined by taking the sum of its connection strengths (co-
expression similarity) with all other genes in the module which the
gene belonged.
Gene Co-expression Network Analysis Clarification
Gene networks provide a convenient framework for exploring
the context within which single genes operate. Networks are
simply graphical models comprised of nodes and edges. For gene
co-expression networks, an edge between two genes may indicate
that the corresponding expression traits are correlated in a given
population of interest. Depending on whether the interaction
strength of two genes is considered, there are two different
approaches for analyzing gene co-expression networks: 1) an
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on the significance of the interactions, and 2) a weighted approach
that avoids hard thresholds. Weighted gene co-expression
networks preserve the continuous nature of gene-gene interactions
at the transcriptional level and are robust to parameter selection.
An important end product from the gene co-expression network
analysis is a set of gene modules in which member genes are more
highly correlated with each other than with genes outside a
module. Most gene co-expression modules are enriched for GO
functional annotations and are informative for identifying the
functional components of the network that are associated with
disease [6].
This gene co-expression network analysis (GCENA) has been
increasingly used to identify gene sub-networks for prioritizing
gene targets associated with a variety of common human diseases
such as cancer and obesity [11,12,13,14,15]. One important end
product of GCENA is the construction of gene modules comprised
of highly interconnected genes. A number of studies have
demonstrated that co-expression network modules are generally
enriched for known biological pathways, for genes that are linked
to common genetic loci and for genes associated with disease
[6,7,11,13,14,15,40,41,42]. In this way, one can identify key
groups of genes that are perturbed by genetic loci that lead to
disease, and that define at the molecular level disease states.
Furthermore, these studies have also shown the importance of the
hub genes in the modules associated with various phenotypes. For
example, GCENA identified ASPM, a hub gene in the cell cycle
module, as a molecular target of glioblastoma [15] and
MGC4504, a hub gene in the unfolded protein response module,
as a target potentially involved in susceptibility to atherosclerosis
[13].
Pathway Analysis
Resulting lists of differentially expressed genes for each growth
factor treatment as well as for each module generated in the
network analysis were analyzed for KEGG (Kyoto Encyclopedia
for Genes and Genome, Kyoto University, Japan) pathway
enrichment using Pathway-Express, a web-based tool freely
available as part of the Onto-Tools (http://vortex.cs.wayne.edu)
[43]. Global literature analysis of various gene lists was performed
using BiblioSphere PathwayEdition (Genomatix Software GmbH,
Munchen, Federal Republic of Germany) software which performs
pathway and interaction analysis and labels genes which belong to
certain known metabolic and signal transduction pathways. A
program based on literature analysis Pathway Studio (Ariadne,
Genomics Inc. Rockville MD) was used to evaluate cellular
processes connected to differentially expressed genes.
Supporting Information
Figure S1 Network scheme for 1540 differentially expressed
genes obtained by global literature analysis using BiblioSphere
Pathway Edition Software (Genomatix Software GmbH,
Munchen, Federal Republic of Germany). Different node colors
represent different modules. A - the whole scheme clearly indicates
5 distinguished groups of genes (each group is shown separately on
pp. 2–6) connected to 5 central genes: Nfkb1 (B, page 2), Vegfa (C,
page 3), Egfr (D, page 4), and Gadd45a (F, page 6). Only
connected genes are shown.
Found at: doi:10.1371/journal.pone.0011637.s001 (2.07 MB
PDF)
Figure S2 KEGG Pathway ‘‘Complement and Coagulation
Cascades’’ enriched by regulated genes from 1,540 gene list. Red
nodes represent up-regulated genes, blue - down-regulated, green -
not affected genes.
Found at: doi:10.1371/journal.pone.0011637.s002 (0.07 MB
PDF)
Figure S3 Scheme of shortest connections to cellular processes
for 55 candidate regulatory genes, as obtained by global literature
analysis using Pathway Studio 7.0 (Ariadne Genomics, Inc.,
Rockville, MD; trial version). Only 22 connected genes from the
list out of 55 are shown, the rest from the list are not connected
and not shown. Node shapes code: oval and circle - protein;
crescent - protein kinase and kinase; diamond - ligand; irregular
polygon - phosphatase; circle/oval on tripod platform - transcrip-
tion factor; ice cream cone - receptor. Red color represents up-
regulated genes, blue color - down regulated genes, grey nodes
represent genes closely connected (next neighbor) to the list genes;
grey rectangles represent cell processes; arrows color: grey solid or
dotted - regulation, blue - expression, green - promoter binding;
arrows with plus sign show positive regulation/activation, arrows
with minus sign - negative regulation/inhibition.
Found at: doi:10.1371/journal.pone.0011637.s003 (0.35 MB
PDF)
Table S1 Rat Genes Expressed Differentially After Growth
Factor Treatment of Ovary. Legends: * - absolute value of
difference between means of Control and GF Treatment
expression values ** - abbreviations used for modules’ color: trq
-turquoise; brw - brown; blu- blue; ylw- yellow; prp - purple; gr -
grey; grn - green; grlw - green-yellow; blc- black; mbl - midnight-
blue; slm - salmon; lcn - light cyan; ***- k in. is connectivity
coefficient determined in network analysis.
Found at: doi:10.1371/journal.pone.0011637.s004 (1.37 MB
PDF)
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